This biotech company was sold off aggressively off the highs but caught buying momentum and covered part of those losses. It penetrated a bit higher then the bears wanted. Nevertheless, 8/21 EMA are hit with today's candle as well as trend line. And it triggers Short Entry below $164.00 with STOP above last swing high at $172 makes this trade attractive from R/R point of view as my target is $140 - low since mid of April. Intermidiate support is at the point of $156 and by coincidence there sits 100 EMA.
